Standout Papers

What the pulmonary specialist should know about the new inhalation therapies 2011 2026 2016 2021 556
  1. What the pulmonary specialist should know about the new inhalation therapies (2011)
    Beth L. Laube, Hettie M. Janssens et al. European Respiratory Journal

Immediate Impact

7 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2025 Standout
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
5 intermediate papers

Works of Mark L. Everard being referenced

PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN- λ production
2018
Persistent and Recurrent Bacterial Bronchitis—A Paradigm Shift in Our Understanding of Chronic Respiratory Disease
2017
and 4 more

Author Peers

Author Last Decade Papers Cites
Mark L. Everard 4032 1485 2127 124 5.1k
Philipp Latzin 3498 918 1152 220 5.3k
Brydon J. B. Grant 2815 1123 1683 91 5.9k
Colin Robertson 4440 838 1269 97 5.3k
Bruce K. Rubin 3561 868 1760 167 6.2k
Michael D. Shields 1772 979 1186 162 3.4k
Mark L Levy 3440 1102 2959 82 5.7k
L. Allegra 2725 1276 1866 155 5.2k
Jeffrey S. Wagener 5132 910 654 97 6.1k
Claire Wainwright 6210 1353 693 182 7.7k
José A. Castro‐Rodríguez 4037 1210 4694 203 7.0k

All Works

Loading papers...

Rankless by CCL
2026